Arcturus Therapeutics Holdings Inc. (ARCT)

Last Closing Price: 12.53 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Arcturus Therapeutics Holdings Inc. (ARCT) had Net Income of $-80.94M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$152.31M
Net Income
$-80.94M
--
$152.31M
$247.98M
$-95.67M
$14.72M
$-80.94M
$-80.94M
$-80.94M
$-80.94M
$-80.94M
$-80.94M
$-95.67M
$-92.12M
27.00M
27.00M
$-3.00
$-3.00
Balance Sheet Financials
$305.98M
$9.53M
$38.09M
$344.07M
$65.49M
--
$37.60M
$103.09M
$240.98M
$240.98M
$240.98M
27.00M
Cash Flow Statement Financials
$-59.75M
$-0.65M
$5.42M
$348.89M
$293.91M
$-54.98M
$37.99M
--
--
Fundamental Metrics & Ratios
4.67
--
--
--
--
100.00%
-62.81%
-62.81%
-60.49%
-53.14%
-53.14%
$-60.40M
--
--
--
0.44
--
38.33
9.52
-33.59%
-33.59%
-23.52%
-33.59%
$8.93
$-2.24
$-2.21